Telesis Bio Inc. — Operating Income by Fiscal Year
4 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6a3a396c-5fa0-4358-9bac-9bd1ed8ebcc4/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2023 | $-46.5M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-038389 |
| FY 2022 | $-46.5M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-009037 |
| FY 2021 | $-35.4M | 2021-01-01 – 2021-12-31 | evidence 0001850079-22-000025 |
| FY 2020 | $-16.4M | 2020-01-01 – 2020-12-31 | evidence 0001850079-22-000025 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).